Experiment summary for ENCSR453MVF

doi:10.17989/ENCSR453MVF

Summary

Status
released
Assay
Mint-ChIP-seq
Target
H3K27ac
Biosample summary
Homo sapiens stimulated activated naive CD8-positive, alpha-beta T cell male adult (33 years) treated with anti-CD3 and anti-CD28 coated beads for 72 hours, 100 ng/mL Interleukin-15 for 72 hours
Biosample Type
primary cell
Replication type
unreplicated
Treatments
anti-CD3 and anti-CD28 coated beads for 72 hours, 100 ng/mL Interleukin-15 (UniProtKB:P40933) for 72 hours
Nucleic acid type
DNA
Controls

Attribution

ENCODE4 project
Lab
Bradley Bernstein, Broad
Award
UM1HG009390 (Bradley Bernstein, Broad)
Project
ENCODE
External resources
Aliases
bradley-bernstein:Project Element 6939
Date released
March 28, 2022

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
11Homo sapiens male adult (33 years) stimulated activated naive CD8-positive, alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 72 hours, 100 ng/mL Interleukin-15 for 72 hoursENCBS261THRENCAB557LLBENCLB123FBH
12Homo sapiens male adult (33 years) stimulated activated naive CD8-positive, alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 72 hours, 100 ng/mL Interleukin-15 for 72 hoursENCBS261THRENCAB557LLBENCLB501HAQ